Bern M, Nilsen J, Ferrarese M, Sand KMK, Gjølberg TT, Lode HE, Davidson RJ, Camire RM, Bækkevold ES, Foss S, Grevys A, Dalhus B, Wilson J, Høydahl LS, Christianson GJ, Roopenian DC, Schlothauer T, Michaelsen TE, Moe MC, Lombardi S, Pinotti M, Sandlie I, Branchini A, Andersen JT (2020). An engineered human albumin enhances half-life and transmucosal delivery when fused to protein-based biologics. Sci Transl Med, 12 (565). PubMed 33055243 DOI 10.1126/scitranslmed.abb0580